Last update 01 Nov 2024

Pts International Inc

Private Company

Overview

Related

1
Drugs associated with Pts International Inc
Para-Toluenesulfonamide
Target
CA2 x CA3
Mechanism
CA2 inhibitors [+1]
Active Org.
Gongwin Biopharm Holdings Co., Ltd.Gongwin Biopharm Holdings Co., Ltd. [+1]
Originator Org.
Tianjin Hongri Jiandakang Medical Technology Co LtdTianjin Hongri Jiandakang Medical Technology Co Ltd
Active Indication
Non-Small Cell Lung Cancer [+1]
Inactive Indication
6-Pyruvoyl-Tetrahydropterin Synthase Deficiency [+4]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date15 Nov 2022
2
Clinical Trials associated with Pts International Inc
NCT03448211 / WithdrawnPhase 1
A Phase I Open-Label, Dose-Escalation Study of Para-toluenesulfonamide Injection (PTS) Administered Intratumorally and Locally to Patients With Solid Tumors
NCT03448146 / CompletedPhase 3
A Phase III Single Arm Trial of PTS (Para Toluenesulfonamide Injection) Via Bronchoscopy Intervention Intratumoral Injection in Patients With Central Air Way NSCLC Tumor Severe Obstruction
100 Clinical Results associated with Pts International Inc
Login to view more data
0 Patents (Medical) associated with Pts International Inc
Login to view more data
100 Deals associated with Pts International Inc
Login to view more data
100 Translational Medicine associated with Pts International Inc
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Para-Toluenesulfonamide
 ( CA2 x CA3 )		Solid tumor
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free